The Indian pharmaceuticals industry is hopeful that the government restores tax benefits that were offered on research and development in Budget 2020. The industry is expecting the government to announce incentives in the upcoming Union Budget to encourage setting up of bulk drug manufacturing units and scale-up spending on healthcare.
In this edition of Reporter's Take, Moneycontrol's Shraddha Sharma gets in conversation with Corporate Bureau Chief Prince Thomas to find out what are the expectations of the phama sector from Finance Minister Nirmala Sitharaman in Budget 2020.
Watch the video for more.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
